TCL Archive Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients October 29, 2010
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review. March 23, 2001
